Autonomous system
AS3902: GlaxoSmithKline
United States · business ISP
Estimated users is a published estimate of how many people use this network, extrapolated from 172 observations over a 60 day window. Large operators often run several networks, so a low figure can mean their customers reach the internet through a sibling network.
What this tells you
- The same operator runs 4 other networks, listed below.
Countries in this space
Space we can place in a country covers 100% of this network's IPv4 space. The table below divides that space.
| Country | IPv4 share | |
|---|---|---|
| United States | 75% | |
| United Kingdom | 25% |
Organisations holding assignments here
Registered organisations account for 25% of this network's IPv4 space. The table below divides that space. Registered holders come from the bulk whois that RIPE, APNIC and AFRINIC publish. ARIN and LACNIC do not publish theirs, so space held in North and South America is largely unattributed here.
| Organisation | IPv4 share | |
|---|---|---|
| Glaxo Wellcome UK Limited | 100% |
Anonymizer signals
None of this space carries an anonymiser or hosting flag.
Other networks from this operator
| ASN | Name | Estimated users |
|---|---|---|
| AS5635 | GlaxoSmithKline | 182 |
| AS14306 | GlaxoSmithKline | 111 |
| AS2539 | GlaxoSmithKline | 89 |
| AS824 | GlaxoSmithKline | - |
See the combined view for GlaxoSmithKline, where all 5 of their networks are totalled together.
Every figure on this page is also JSON: /api/v2/directory/asn/3902. Breakdowns paginate from there, so a table showing the largest rows here returns all of them. Read the API.